TSS
LPCN icon

Two Sigma Securities’s Lipocine LPCN Stock Holding History

Two Sigma Securities’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-988
Closed -$6.68K – 3010
2022
Q4 		$6.68K Buy
+988
New +$7.2K ﹤0.01% 2424
2022
Q2 		– Sell
-1,112
Closed -$26K – 2585
2022
Q1 		$26K Buy
+1,112
New +$23.3K ﹤0.01% 1943
2017
Q3 		– Sell
-1,419
Closed -$97K – 1088
2017
Q2 		$97K Buy
+1,419
New +$92.6K 0.02% 656

Other funds holding LPCN

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Securities's LPCN Position: Q1 2023 in Review

Two Sigma Securities sold out of Lipocine (LPCN) in Q1 2023, closing a stake of 988 shares — an estimated $6.68K sold.

Two Sigma Securities first reported a position in LPCN in Q2 2017 and held it in 3 quarters. The position peaked at $97K in Q2 2017. 45 funds tracked by Wall St. Rank hold LPCN as of Q1 2023.

  • Two Sigma Securities reported no remaining Lipocine position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 988 Lipocine shares in Q1 2023, an estimated $6.68K.
  • Two Sigma Securities first reported a position in Lipocine in Q2 2017 and held it in 3 quarters.
  • Two Sigma Securities's Lipocine position peaked at $97K in Q2 2017.
  • 45 funds tracked by Wall St. Rank held Lipocine as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.